SEI Trust Company’s Biogen BIIB Stock Holding History

SEI Trust Company’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$114M	Buy	344,375 +17,832	+5%	+$5.88M	1.1%	9
2014 Q2	$103M	Sell	326,543 -5,692	-2%	-$1.71M	0.99%	9
2014 Q1	$102M	Sell	332,235 -53,339	-14%	-$16.9M	1.01%	9
2013 Q4	$108M	Buy	385,574 +20,557	+6%	+$5.32M	1.02%	10
2013 Q3	$87.9M	Buy	365,017 +9,435	+3%	+$2.11M	0.97%	12
2013 Q2	$76.5M	Buy	+355,582	New	+$76M	0.94%	11

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SEI Trust Company's BIIB Position: Q3 2014 in Review

SEI Trust Company increased its Biogen (BIIB) stake by 5.5% in Q3 2014, buying an estimated $5.88M and bringing the position to 344,375 shares worth $114M. The position accounts for 1.1% of the portfolio, ranked #9.

SEI Trust Company first reported a position in BIIB in Q2 2013 and has held it in 6 quarters since. 819 funds tracked by Wall St. Rank hold BIIB as of Q3 2014.

SEI Trust Company held 344,375 shares of Biogen worth $114M as of Q3 2014.
SEI Trust Company bought 17,832 Biogen shares in Q3 2014, an estimated $5.88M.
Biogen made up 1.1% of SEI Trust Company's portfolio in Q3 2014, its #9 holding.
SEI Trust Company first reported a position in Biogen in Q2 2013 and has held it in 6 quarters since.
819 funds tracked by Wall St. Rank held Biogen as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.